• Home
  • Shanghai Henlius Biotech, Inc.

Shanghai Henlius Biotech, Inc.

About Shanghai Henlius Biotech, Inc.

We are a leading biopharmaceutical company in China with the vision to offer high-quality, affordable and innovative biologics for patients worldwide with a focus on oncology and autoimmune diseases. Since our inception in 2010, we have built an integrated and efficient global R&D platform with key facilities in Shanghai, Taipei and California. Our three R&D centers closely collaborate with each o...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2019
    On CPHI since
View company profile
Contact info
  • Website
  • 9/F Innov TowerZone ANO 1801 HongMei Rd., 200233, Shanghai, China
Show contact info Hide contact info

Products from Shanghai Henlius Biotech, Inc. (1)

  • 汉利康® (pronounced as Han-Li-Kang) Rituximab Injection

    Product 汉利康® (pronounced as Han-Li-Kang) Rituximab Injection

    汉利康® (pronounced as Han-Li-Kang) Rituximab Injection.  It is the first-ever China-manufactured biosimilar approved by the NMPA for the treatment of non-Hodgkin lymphoma (NHL).  Meanwhile, we are also conducting a Phase 3 clinical trial for rheumatoid arthritis (RA) for HLX01 in China.  ...

Shanghai Henlius Biotech, Inc. Resources (1)